Breast focused ultrasound surgery with magnetic resonance guidance

Topics in Magnetic Resonance Imaging

Volumn 17, Issue 3, 2006, Pages 181-188

  Gombos, Eva C ^a   Kacher, Daniel F ^a   Furusawa, Hidemi ^b   Namba, Kiyoshi ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Breastopia Namba Hospital   (Japan)

Author keywords

Breast conservation therapy; FUS; HIFU; Lumpectomy; MR guided focused ultrasound surgery; MRI guided therapy

Indexed keywords

BREAST CANCER; BREAST CARCINOMA; BREAST TUMOR; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOPATHOLOGY; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; THERMOREGULATION; ULTRASOUND TRANSDUCER;

ADULT; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FIBROADENOMA; HUMANS; MAGNETIC RESONANCE IMAGING; ULTRASONIC THERAPY;

EID: 34247175837     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b013e318033789f     Document Type: Review

References (40)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
3. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232.
4. Bartelink H, Horiot JC, Poortmans P. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378-1387.
5. Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326-2333.
6. Agnese DM, Burak WE Jr. Ablative approaches to the minimally invasive treatment of breast cancer. Cancer J. 2005;11:77-82.
7. Kaufman CS, Littrup PJ, Freeman-Gibb LA, et al. Office-based cryoablation of breast fibroadenomas with long-term follow-up. Breast J. 2005;11:344-350.
8. Copeland EM III, Bland KI. Are minimally invasive techniques for ablation of breast cancer ready for "prime time"? Ann Surg Oncol. 2004;11:115-116.
9. Kacher DF, Jolesz FA. MR imaging-guided breast ablative therapy. Radiol Clin North Am. 2004;42:947-62. vii.
10. Morin J, Traore A, Dionne G, et al. Magnetic resonance-guided percutaneous cryosurgery of breast carcinoma: technique and early clinical results. Can J Surg. 2004;47:347-351.
11. Sabel MS, Kaufman CS, Whitworth P, et al. Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial. Ann Surg Oncol. 2004;11:542-549.
12. Singletary SE. Minimally invasive techniques in breast cancer treatment. Semin Surg Oncol. 2001;20:246-250.
13. Dowlatshahi K, Francescatti DS, Bloom KJ. Laser therapy for small breast cancers. Am J Surg. 2002;184:359-363.
14. Pfleiderer SO, Freesmeyer MG, Marx C, et al. Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur Radiol. 2002;12:3009-3014.
15. Gianfelice D, Khiat A, Amara M, et al. MR imaging-guided focused US ablation of breast cancer: histopathologic assessment of effectiveness - initial experience. Radiology. 2003;227:849-855.
16. Hynynen K, Pomeroy O, Smith DN, et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology. 2001;219:176-185.
17. Wu F, Wang ZB, Cao YD, et al. A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer. Br J Cancer. 2003;89:2227-2233.
18. Huber PE, Jenne JW, Rastert R, et al. A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res. 2001;61:8441-8447.
19. Gianfelice D, Khiat A, Boulanger Y, et al. Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma. J Vasc Interv Radiol. 2003;14:1275-1282.
20. Gianfelice D, Khiat A, Amara M, et al. MR imaging-guided focused ultrasound surgery of breast cancer: correlation of dynamic contrast-enhanced MRI with histopathologic findings. Breast Cancer Res Treat. 2003;82:93-101.
21. Zippel DB, Papa MZ. The use of MR imaging guided focused ultrasound in breast cancer patients; a preliminary phase one study and review. Breast Cancer. 2005;12:32-38.
22. Furusawa H, Namba K, Thomsen S, et al. Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg. 2006;203:54-63.
23. Palussiere J, Salomir R, Le BB, et al. Feasibility of MR-guided focused ultrasound with real-time temperature mapping and continuous sonication for ablation of VX2 carcinoma in rabbit thigh. Magn Reson Med. 2003;49:89-98.
24. Wu F, Chen WZ, Bai J, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2001;27:1099-1106.
25. Wu F, Wang ZB, Cao YD, et al. Heat fixation of cancer cells ablated with high-intensity-focused ultrasound in patients with breast cancer. Am J Surg. 2006;192:179-184.
26. Vargas HI, Dooley WC, Gardner RA, et al. Success of sentinel lymph node mapping after breast cancer ablation with focused microwave phased array thermotherapy. Am J Surg. 2003;186:330-332.
27. Wu F, Wang ZB, Zhu H, et al. Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat. 2005;92:51-60.
28. Coad JE, Kosari K, Humar A, et al. Radiofrequency ablation causes 'thermal fixation' of hepatocellular carcinoma: a post-liver transplant histopathologic study. Clin Transplant. 2003;17:377-384.
29. Rajan R, Poniecka A, Smith TL, et al. Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response. Cancer. 2004;100:1365-1373.
30. Mamounas EP, Fisher B. Preoperative (neoadjuvant) chemotherapy in patients with breast cancer. Semin Oncol. 2001;28:389-399.
31. Abrial C, Mouret-Reynier MA, Amat S, et al. Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancers. Med Oncol. 2005;22:233-240.
32. Bohris C, Jenne JW, Rastert R, et al. MR monitoring of focused ultrasound surgery in a breast tissue model in vivo. Magn Reson Imaging. 2001;19:167-175.
33. Hynynen K, McDannold N, Mulkern RV, et al. Temperature monitoring in fat with MRI. Magn Reson Med. 2000;43:901-904.
34. Hynynen K, Freund WR, Cline HE, et al. A clinical, noninvasive, MR imaging-monitored ultrasound surgery method. Radiographics. 1996;16:185-195.
35. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol. 2003;181:619-626.
36. Morris EA. Breast cancer imaging with MRI. Radiol Clin North Am. 2002;40:443-466.
37. Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology. 2006;238:42-53.
38. Hynynen K, Chung AH, Colucci V, et al. Potential adverse effects of high-intensity focused ultrasound exposure on blood vessels in vivo. Ultrasound Med Biol. 1996;22:193-201.
39. Dillon MF, Hill AD, Quinn CM, et al. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol. 2006;13:333-339.
40. Silverstein MJ, Gierson ED, Colburn WJ, et al. Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors. Cancer. 1994;73:2985-2989.